These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39326894)

  • 1. Revealing the mechanism of Gualou-Xiebai against myocardial ischemia based on network pharmacology and energy metabolism strategies.
    Jiang Q; Wen Y; Chen P; Hong X; Qian R; Liu J; Li J; Huang F; Han L
    Biomed Chromatogr; 2024 Dec; 38(12):e6007. PubMed ID: 39326894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deciphering the combination mechanisms of Gualou-Xiebai herb pair against atherosclerosis by network pharmacology and HPLC-Q-TOF-MS technology.
    Liu Y; Zhong H; Xu P; Zhou A; Ding L; Qiu J; Wu H; Dai M
    Front Pharmacol; 2022; 13():941400. PubMed ID: 36120369
    [No Abstract]   [Full Text] [Related]  

  • 3. Integration of metabolomics and transcriptomics to reveal anti-chronic myocardial ischemia mechanism of Gualou Xiebai decoction.
    Zhang F; Duan B; Zhou Z; Han L; Huang P; Ye Y; Wang Q; Huang F; Li J
    J Ethnopharmacol; 2022 Oct; 297():115530. PubMed ID: 35830899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A UHPLC-Q-TOF-MS-based serum and urine metabolomics approach reveals the mechanism of Gualou-Xiebai herb pair intervention against atherosclerosis process in ApoE
    Wang Y; Sun X; Qiu J; Zhou A; Xu P; Liu Y; Wu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Jan; 1215():123567. PubMed ID: 36529071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gualou-Xiebai herb pair and its active ingredients act against atherosclerosis by suppressing VSMC-derived foam cell formation via regulating P2RY12-mediated lipophagy.
    Bao Y; Zhu L; Wang Y; Liu J; Liu Z; Li Z; Zhou A; Wu H
    Phytomedicine; 2024 Jun; 128():155341. PubMed ID: 38518636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolites profile of Gualou Xiebai Baijiu decoction (a classical traditional Chinese medicine prescription) in rats by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
    Lin P; Qin Z; Yao Z; Wang L; Zhang W; Yu Y; Dai Y; Zhou H; Yao X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1085():72-88. PubMed ID: 29635208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of the mechanisms and major bioactive compounds responsible for the protective effects of Gualou Xiebai Decoction on coronary heart disease by network pharmacology analysis.
    Li C; Zhang WY; Yu Y; Cheng CS; Han JY; Yao XS; Zhou H
    Phytomedicine; 2019 Mar; 56():261-268. PubMed ID: 30668346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gualou xiebai decoction ameliorates cardiorenal syndrome type II by regulation of PI3K/AKT/NF-κB signalling pathway.
    Wang YY; Liu YY; Li J; Zhang YY; Ding YF; Peng YR
    Phytomedicine; 2024 Jan; 123():155172. PubMed ID: 37976694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating serum pharmacochemistry, network pharmacology and untargeted metabolomics strategies to reveal the material basis and mechanism of action of Feining keli in the treatment of chronic bronchitis.
    Zhu Z; Feng YD; Zou YL; Xiao YH; Wu JJ; Yang YR; Jiang XX; Wang L; Xu W
    J Ethnopharmacol; 2024 Dec; 335():118643. PubMed ID: 39089660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular mechanism of Dalbergia cochinchinensis heartwood in regulation of energy metabolism to treat myocardial ischemia based on network pharmacology and experimental validation].
    Cheng LH; Chen LY; Shou BY; Luo YY; Cui YR; Liu RH
    Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6696-6708. PubMed ID: 36604920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Compatibility mechanism of Qishen Yiqi Dripping Pills for treatment of myocardial ischemia based on UPLC-Q-Exactive Orbitrap-MS and network pharmacology].
    Liu Y; Jia MX; Zhao T; Wu C; Sun J; Dong L
    Zhongguo Zhong Yao Za Zhi; 2024 Jul; 49(14):3769-3783. PubMed ID: 39099351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Explore the Potential Mechanism of Gualou Xiebai Banxia Decoction against Myocardial Infarction.
    Wang WL; Chen Y
    Genes (Basel); 2024 Mar; 15(4):. PubMed ID: 38674327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology analysis and experimental validation to explore the mechanism of Shenlian extract on myocardial ischemia.
    Li JJ; Wang CM; Wang YJ; Yang Q; Cai WY; Li YJ; Song M; Zang YL; Cui XH; Li Q; Chen Y; Weng XG; Zhu XX
    J Ethnopharmacol; 2022 Apr; 288():114973. PubMed ID: 34990768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the mechanisms of Buyang Huanwu Decoction in treating chronic cerebral ischemia: A combined approach using network pharmacology, molecular docking, and in vivo validation.
    Cao Y; Yao W; Yang T; Yang M; Liu Z; Luo H; Cao Z; Chang R; Cui Z; Zuo H; Liu B
    Phytomedicine; 2024 Sep; 132():155820. PubMed ID: 39004032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network Pharmacology and Molecular Docking-Based Analysis on Bioactive Anticoronary Heart Disease Compounds in
    Yu YD; Hou WJ; Zhang J; Xue YT; Li Y
    Evid Based Complement Alternat Med; 2021; 2021():6704798. PubMed ID: 34824593
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrated network pharmacology and serum metabonomics analysis to explore the potential mechanism of Anemarrhena asphodeloides Bunge-Phellodendron chinense Schneid herb pair in the treatment of benign prostatic hyperplasia.
    Cheng C; Xu C; Zhou W; Xue L; Wang S; Zhai Q; Dai R
    J Pharm Biomed Anal; 2024 Sep; 248():116264. PubMed ID: 38889577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network pharmacology analysis and experimental verification of the antithrombotic active compounds of trichosanthis pericarpium (Gualoupi) in treating coronary heart disease.
    Xia KR; Zhang XY; Zhang HQ; Su KL; Shang EX; Xiao QL; Li WW; Guo S; Duan JA; Liu P
    J Ethnopharmacol; 2024 Jul; 329():118158. PubMed ID: 38614263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gualou-Xiebai herb pair ameliorate atherosclerosis in HFD-induced ApoE
    Zhu L; Bao Y; Liu Z; Liu J; Li Z; Sun X; Zhou A; Wu H
    J Ethnopharmacol; 2024 May; 326():117892. PubMed ID: 38350505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extract of Gualou-Xiebai Herb Pair Improves Lipid Metabolism Disorders by Enhancing the Reverse Cholesterol Transport in Atherosclerosis Mice.
    Liu Y; Wang T; Ding L; Li Z; Zhang Y; Dai M; Wu H
    Curr Neurovasc Res; 2024; 21(2):214-227. PubMed ID: 38629368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrated Analysis of Network Pharmacology and Experimental Validation to Reveal the Mechanism of Chinese Medicine Formula Naotaifang in Treating Cerebral Ischemia-Reperfusion Injury.
    Yang T; Chen X; Mei Z; Liu X; Feng Z; Liao J; Deng Y; Ge J
    Drug Des Devel Ther; 2021; 15():3783-3808. PubMed ID: 34522084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.